Relationship between inflammation/immunity and epilepsy: A multi-omics mendelian randomization study integrating...

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Emerging evidence links activated innate and adaptive immunity to inflammation, a process implicated in epileptogenesis.
• The precise biological mechanisms connecting inflammation/immunity to epilepsy remain largely uncharacterized.

Purpose of the Study:

• To investigate the causal relationships between inflammation/immune-related genes and epilepsy using a multi-omics Mendelian randomization (MR) approach.
• To identify specific genes and biological pathways involved in the immune-mediated etiology of epilepsy.

Main Methods:

• Utilized a summary-data-based Mendelian randomization (SMR) approach, integrating genome-wide association study (GWAS) data for epilepsy with cis-expression quantitative trait loci (cis-eQTL) and cis-methylation quantitative trait loci (cis-mQTL) data.
• Performed sensitivity analyses using five additional MR methods to ensure the robustness of identified causal associations.
• Conducted functional enrichment analysis on key genes to elucidate their biological functions in epilepsy pathogenesis.

Main Results:

• Analysis of 386 inflammation/immune-related genes revealed potential causal links.
• Primary SMR analysis identified 37 DNA methylation sites and six regulated genes associated with epilepsy.
• MR analysis pinpointed three genes with a causal effect on epilepsy: VEGFA (negatively correlated), IL16 (positively correlated), and HLA-DPA1 (positively correlated).
• Functional enrichment highlighted gene involvement in VEGF activation signaling and chemotaxis regulation.

Conclusions:

• This study provides robust evidence for the causal role of inflammation and immunity in the development of epilepsy.
• The identified genes, particularly IL16 and HLA-DPA1, represent promising candidates for targeted therapeutic strategies and drug development in epilepsy treatment.